EEG Characteristics in ECT
Brief Summary
The investigators will be examining slow-wave characteristics in depressed patients receiving electroconvulsive therapy (ECT) using direct current electroencephalogram (dcEEG) by anesthesia induction agent.
Condition or Disease
- Electroconvulsive Therapy
- Direct Current Electroencephalogram
- Ketamine
- Spreadind Depression
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Not yet recruiting |
| Study results: | No Results Available |
| Age: | 18 Years to 65 Years (Adult, Older Adult) |
| Enrollment: | 26 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Oct 01, 2019 | |
|---|---|---|
| Primary Completion: | Oct 01, 2020 | |
| Completion Date: | Oct 01, 2020 | |
| Study First Posted: | Jul 17, 2019 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Jul 19, 2019 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
This is a pilot project using dcEEG to look at infra-slow waves in depressed patients receiving ECT randomized to ketamine or methohexital where ketamine suppresses infra-slow waves. The rationale for this project is to identify biomarkers of treatment adequacy in ECT, which could lead to decreased morbidity and mortality with the procedure and lessen the burden of depression in our patient population.
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 65 |
More Details
| NCT Number: | NCT04022226 |
|---|---|
| Other IDs: | 19-228 |
| Study URL: | https://ClinicalTrials.gov/show/NCT04022226 |
Last updated: Feb 22, 2021